Management of Chronic Diarrhoea: A Structured Approach
The management of chronic diarrhoea requires a systematic diagnostic approach followed by targeted treatment based on the underlying cause, with loperamide being the first-line symptomatic treatment for uncomplicated cases.
Initial Assessment
Definition and Classification
- Chronic diarrhoea is defined as the abnormal passage of loose or liquid stools more than three times daily and/or stool volume greater than 200g/day for more than 4 weeks 1
- Use the Bristol Stool Chart to assess consistency (type 5 and above indicates diarrhoea) 1
Key History Elements
- Duration and pattern of symptoms
- Stool characteristics (frequency, consistency, volume, presence of blood)
- Nocturnal diarrhoea (suggests organic disease)
- Recent travel history
- Medication review (including antibiotics)
- Previous surgeries (especially intestinal resections)
- Family history of IBD, coeliac disease, or colorectal cancer
- Dietary factors (lactose, fructose, sorbitol, high FODMAP foods)
- Associated symptoms (weight loss, abdominal pain, fever)
Diagnostic Algorithm
Primary Care Investigations
Blood tests:
- Full blood count
- C-reactive protein and ESR
- Electrolytes and renal function
- Liver function tests
- Thyroid function tests
- Coeliac serology (tissue transglutaminase antibodies)
Stool tests:
- Microscopy, culture, and sensitivity
- Clostridium difficile toxin
- Faecal calprotectin (to detect inflammation)
- Faecal occult blood test
Secondary Care Investigations (Based on Initial Findings)
Endoscopic evaluation:
- Colonoscopy with ileal intubation and biopsies (particularly in patients >45 years)
- Upper GI endoscopy with duodenal biopsies (if coeliac disease suspected)
Specialized tests (as indicated):
- SeHCAT scan for bile acid malabsorption
- Hydrogen/methane breath tests for carbohydrate malabsorption or bacterial overgrowth
- Pancreatic function tests
- CT or MRI enterography for small bowel assessment
Treatment Approach
Symptomatic Management
First-line antidiarrheal:
Dietary modifications:
Hydration:
- Ensure adequate oral hydration and electrolyte replacement 2
Cause-Specific Treatment
Inflammatory Bowel Disease:
- Anti-inflammatory medications (5-ASA, corticosteroids)
- Immunomodulators or biologics as indicated
Microscopic Colitis:
- Budesonide 9 mg daily for induction of remission 1
Bile Acid Malabsorption:
- Bile acid sequestrants (cholestyramine, colestipol, colesevelam) 1
Small Bowel Bacterial Overgrowth:
- Antibiotics (rifaximin preferred due to minimal systemic absorption) 4
- Treat underlying causes
Coeliac Disease:
- Strict gluten-free diet
Chemotherapy-induced Diarrhoea:
Functional Diarrhoea/IBS-D:
Monitoring and Follow-up
- Track stool frequency and consistency during treatment
- Review after 4-6 weeks of initial treatment
- If no improvement or worsening symptoms, reassess diagnosis and consider additional investigations
- Monitor for complications such as dehydration, electrolyte imbalances, and malnutrition
Red Flags Requiring Urgent Attention
- Severe dehydration or electrolyte disturbances
- Significant weight loss
- Bloody diarrhoea
- Fever
- Severe abdominal pain
- Diarrhoea in immunocompromised patients
- Chemotherapy-induced diarrhoea with signs of enterocolitis 1
Special Considerations
- Elderly patients: More susceptible to dehydration, electrolyte imbalances, renal function decline, and malnutrition 1
- Cancer patients: Consider chemotherapy-related causes; 74% of patients >65 years report diarrhoea during chemotherapy 1
- Post-surgical patients: Consider bile acid malabsorption, small bowel bacterial overgrowth, or dumping syndrome 1, 6
Remember that chronic diarrhoea significantly impacts quality of life through stool frequency, urgency, and potential incontinence. Targeted treatment based on accurate diagnosis is essential for improving patient outcomes and reducing morbidity.